<DOC>
	<DOCNO>NCT00360763</DOCNO>
	<brief_summary>The autoantibody AT1 receptor ( ATR-AA ) , behave like agonist detect patient hypertension . ATR-AA block ARB may play role pathogenesis hypertension . The present study explore whether AT1 receptor blocker superior anti-hypertensive effect patient positive ATR-AA hypertension . Patients 2 grade hypertension recruit ATR-AA assay ELISA . A study carry efficacy anti-hypertension compare candesartan cilexetil ACE inhibitor imidapril .</brief_summary>
	<brief_title>Study Optimal Treatment Plan Hypertensives With Anti-AT1-Receptor Autoantibody</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Hypertension ( 2 grade ) Secondary hypertension Known sensitivity intolerance angiotensin II receptor antagonist ACE inhibitor Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>